Menu

Close

Nix induced mitochondrial fission, mitophagy, and myocyte insulin resistance are abrogated by PKA phosphorylation

Simone Cristina da Silva Rosa, Matthew D. Martens, Jared T. Field, Lucas Nguyen, Stephanie M. Kereliuk, Yan Hai, Donald Chapman, William Diehl-Jones, Michel Aliani, Adrian R. West, James Thliveris, Saeid Ghavami, Christof Rampitsch, Vernon W. Dolinsky, Joseph W. Gordon

Preprint posted on November 04, 2019 https://www.biorxiv.org/content/10.1101/825828v1.full

Nix's function beyond mitophagy: role of a lipotoxicity-induced Nix in myocyte insulin resistance.

Selected by Sandra Franco Iborra

Categories: cell biology

This work establishes a connection between lipotoxicity, mitophagy activation and reduced insulin sensitivity in skeletal muscle cells. Lipotoxicity is a stress insult caused by the accumulation of lipid intermediates resulting in insulin resistance. The muscle tissue is central to this concept since most of the postprandial glucose uptake occurs in the muscle (Shulman et al., 1990). Indeed rodents fed a high-fat diet accumulate diacylglycerols, ceramides and triglycerides in the muscle tissue, leading to the activation of signaling pathways (Yu et al., 2002; Itani et al., 2002) that have been shown to inhibit the insulin receptor substrate-1 (IRS1) (Li et al., 2014). Altered muscle mitochondrial function is intimately linked to obesity and insulin resistance (Lowell & Shulman 2005; Szendroedi et al., 2011). Mitophagy ensures the quality of the mitochondrial pool by selectively eliminating those dysfunctional mitochondria. Dysfunctional mitochondria are specifically recognized by receptors that connect the mitochondria with LC3-II in the autophagosomal membrane. Some receptors can be mitochondrial proteins (Nix, FUNDC1, PHB) while others are non-mitochondrial proteins that recognize ubiquitinated chains on the mitochondrial surface (Martinez-Vicente, 2017). Excessive removal of dysfunctional mitochondria by mitophagy in the muscle has been suggested to contribute to muscle insulin resistance (Fu et al., 2018).

Previous work performed by the authors showed increased expression of the mitophagy receptor Nix upon lipotoxicity (Mughal et al., 2015). In this manuscript, the authors explore the mechanisms of lipotoxicity-mediated Nix activation and undercover new roles for Nix beyond mitophagy induction.

Key findings

High-fat diet led to increases in lipid species in rat soleus muscle including diacylglycerols, ceramides, triglycerides, phosphatidic acid and alterations in cardiolipin composition. Autophagy-related genes (such as Beclin-1, ATG3, -5, -12) were moderately decreased, together with PGC-1α and some mitochondrial enzymes. Previous work has already shown that high-fat diet induces the expression of Nix, which is a known mitophagy receptor (Mughal et al., 2015).

Overexpression of Nix in C2C12 myoblasts led to increased mitochondrial fragmentation, presumably due to calcium-mediated dephosphorylation of DRP1, increased mitophagy and altered insulin-stimulated glucose uptake. Lipotoxicity induction using palmitate treatment recapitulated those phenotypes and also stimulated increased Nix expression. Importantly, Nix knockdown abrogated mitochondrial fragmentation, increased mitophagy and altered glucose uptake. Therefore, in addition to its role as a mitophagy receptor, Nix is an important regulator of lipotoxicity-induced mitochondrial dysfunction, mitophagy and insulin resistance.

The next step was to investigate which signaling pathway could be regulating Nix function. It turns out that Nix contains a conserved PKA consensus motif that can be phosphorylated at Serine-212. Treatment of C2C12 myoblasts with pharmacological PKA activators led to increased phospho-Nix (pNix) and prevention of Nix-induced mitochondrial depolarization, suggesting that Ser-212 could represent an inhibitory phosphorylation site. To confirm this hypothesis, C2C12 cells were treated with palmitate and pharmacological PKA activators. PKA activation in palmitate-treated cells led to the rescue of mitochondrial depolarization, mitochondrial fragmentation and mitophagy induction and activation of insulin-stimulated glucose uptake. Thus, Ser-212 is a PKA phosphorylation site that modulates Nix-induced mitophagy and insulin sensitivity.

Moreover, cell fractionation studies indicate that pNix is exclusively localized to the cytosolic fraction. Interestingly, PKA-responsive Ser-212 is localized to the conserved interacting domain of the molecular chaperone family 14-3-3. Could this family of chaperones be responsible for Nix translocation from ER and/or mitochondria to the cytosol? Indeed, Nix co-immunoprecipitates with 14-3-3β chaperone and this interaction is enhanced upon treatment with pharmacological PKA activators. Moreover, co-expression of Nix and 14-3-3β counteracts Nix effects on mitochondrial function, mitophagy and insulin sensitivity.

One interesting observation is the relationship between Nix activation and insulin resistance. Nix overexpression in C2C12 myotubes leads to IRS1 phosphorylation and inhibition. IRS1 Ser-1101 phosphorylation has been shown to be mediated by PKC Ө and/or p70S6K. At the same time, phosphatidic acids are direct activators of the mTOR-p70S6K pathway. Interestingly, Nix overexpression or palmitate treatment in C2C12 myoblasts increased p70S6K phosphorylation in a Nix-dependent manner. On the other hand, phospholipase 6 knockdown prevents p70S6K expression, presumably due to the lack of phospholipase 6 activity that leads to decreased phosphatidic acid levels. These observations point at a link between excessive mitochondrial turnover and impaired insulin sensitivity.

Lipotoxicity-induced Nix overexpression leads to DRP1-mediated mitochondrial fragmentation, increased mitochondrial turnover and desensitization of insulin receptor signaling. PKA activation inhibits Nix function and restores insulin signaling. 

Overall, this manuscript shares light on the signaling cascade triggered by lipotoxicity in the muscle and suggests that PKA pharmacological activation might promote insulin responsiveness in the myocytes.

Why I like this preprint

The mitophagy field has experienced exponential growth in the past decade. However, most of the work is focused on non-mitochondrial receptors and PINK1/parkin mitophagy. Nix was originally described to play a role in mitophagy taking place during reticulocyte maturation, when mitochondria have to be eliminated from the erythrocyte (Schweers et al 2007; Sandoval et al 2008). However, mitophagy is also a mechanism that allows the regulation of mitochondrial content in response to changing metabolic conditions. This manuscript describes a link between increased lipid content, activation of a mitophagy receptor and increased mitochondrial turnover. Moreover, the results shown here increase our understanding of Nix function and regulation beyond mitophagy.

Questions for the authors

  • The metabolomic studies performed in rats fed with high-fat diet show alterations in cardiolipin composition. Cardiolipin is a critical inner mitochondrial membrane lipid involved in mitochondrial cristae morphology and stability. Do you think that changes in cardiolipin composition can lead to mitochondria dysfunction? Which would be the relationship between alterations in cardiolipin composition and Nix function?
  • Nix is a protein that contains a transmembrane domain and that has been described in the outer mitochondrial membrane. How would you explain that mitochondrial-targeted Nix constructs don’t stimulate mitophagy, while the ER/SR targeted ones do?
  • How do you reconcile the fact that there is a moderate downregulation in autophagy-related genes upon lipotoxic stress, while mitophagy is being stimulated?

References

  • Fu T, Xu Z, Liu L, Guo Q, Wu H, Liang X, Zhou D, Xiao L, Liu L, Liu Y, et al. Mitophagy Directs Muscle-Adipose Crosstalk to Alleviate Dietary Obesity. Cell Rep 2018; 23:1357–72.
  • Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51:2005–11.
  • Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem 2004; 279:45304–7.
  • Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-7.
  • Martinez-Vicente M. Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci 2017;10:64.
  • Mughal W, Nguyen L, Pustylnik S, da Silva Rosa SC, Piotrowski S, Chapman D, Du M, Alli NS, Grigull J, Halayko AJ, et al. A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells. Cell Death Dis 2015; 6:e1944.
  • Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322:223–8.
  • Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2011; 8:92-103.
  • Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277:50230–6.

 

 

Tags: insulin-resistance, mitophagy, muscle

Posted on: 13th December 2019

Read preprint (No Ratings Yet)




  • Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    preLists in the cell biology category:

    ASCB EMBO Annual Meeting 2019

    A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)

     



    List by Madhuja Samaddar, Ramona Jühlen, Amanda Haage, Laura McCormick, Maiko Kitaoka

    EMBL Seeing is Believing – Imaging the Molecular Processes of Life

    Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019

     



    List by Gautam Dey

    Autophagy

    Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.

     



    List by Sandra Malmgren Hill

    Lung Disease and Regeneration

    This preprint list compiles highlights from the field of lung biology.

     



    List by Rob Hynds

    Cellular metabolism

    A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.

     



    List by Pablo Ranea Robles

    BSCB/BSDB Annual Meeting 2019

    Preprints presented at the BSCB/BSDB Annual Meeting 2019

     



    List by Gautam Dey

    MitoList

    This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.

     



    List by Sandra Franco Iborra

    Biophysical Society Annual Meeting 2019

    Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA

     



    List by Joseph Jose Thottacherry

    ASCB/EMBO Annual Meeting 2018

    This list relates to preprints that were discussed at the recent ASCB conference.

     



    List by Gautam Dey, Amanda Haage
    Close